Mariana Socal
Biographic Data
| ID | 1781936 |
|---|---|
| NAME | Mariana Socal |
| GIVEN NAMES | Mariana |
| FAMILY NAME | Socal |
| SIGNATURE | SOCAL M |
| AFFILIATIONS | Johns Hopkins University |
| ORCID | 0000-0001-9459-4898 |
| VERIFIED | Yes |
| TOTAL WORKS | 9 |
| TOTAL CITATIONS | 7 |
| AUTHOR COUNT | 9 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2016 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 1 |
US Antibiotic Importation and Supply Chain Vulnerabilities
This study found that US antibiotic importation relies on diversified global sources for FDFs but primarily on China for APIs. Policies to strengthen domestic production and diversify sourcing are critical to mitigate supply chain vulnerabilities. Improved traceability and targeted strategies for specific antibiotics are recommended to safeguard public health and national security
Trends of Prescription Drug Manufacturer Rebates in Commercial Health Insurance Plans, 2015-2019
This economic evaluation examines the magnitude and trend of prescription drug rebates in commercial markets from 2015 to 2019 and identifies insurance plan factors associated with rebates
Impacts of the 2017 Brazilian National Primary Care Policy on public primary health care in Rio de Janeiro, Brazil
In 2017, in a scenario of financial restrictions caused by an economic crisis in Brazil, a new primary health care policy promoted changes in the way different primary health care models were prioritized and implemented, with possible negative effects on the access to primary health care. This study aims to investigate if the 2017 Brazilian National Primary Care Policy (PNAB) negatively affected the primary care organization based on the Family H…
The Pandemic and the Supply Chain: Gaps in Pharmaceutical Production and Distribution
Older Americans’ Preferences Between Lower Drug Prices and Prescription Drug Plan Choice, 2019
Objectives. To assess older Americans’ willingness to trade off the possibility of choosing or changing their prescription drug plan for lower drug spending. Methods. We used data from the Kaiser Family Foundation Health Tracking Poll on prescription drugs carried out in February 2019. This nationwide telephone survey oversampled participants aged 65 years and older who, when weighted, were representative of the US older adult population. Results…
Critical Drugs for Critical Care: Protecting the US Pharmaceutical Supply in a Time of Crisis
Critical Drugs for Critical Care: Protecting the US Pharmaceutical Supply in a Time of Crisis Mariana P. Socal MD, PhD, Joshua M. Sharfstein MD, and Jeremy A. Greene MD, PhD Affiliation Mariana P. Socal and Joshua M. Sharfstein are with the Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. Jeremy A. Greene is with the Department of History of Medicine and the Center for Medical Humanities …
Judicialization 2.0: Understanding right-to-health litigation in real time
Over the past two decades, debate over the whys, the hows, and the effects of the ever-expanding phenomenon of right-to-health litigation ('judicialization') throughout Latin America have been marked by polarised arguments and limited information. In contrast to claims of judicialization as a positive or negative trend, less attention has been paid to ways to better understand the phenomenon in real time. In this article, we propose a new approac…
Links Between Chronic Illness and Late-Life Cognition: Evidence From Four Latin American Countries
These results suggest that returns from preventive policies to reduce cognitive decline would increase if they were targeted to seniors with chronic conditions and implemented before the impact from multiple comorbidities makes the cognitive decline too steep to be reversed
The challenging nature of gathering evidence and analyzing the judicialization of health in Brazil
de coletar evidncias e analisar a judicializao da sade no Brasil La desafiante naturaleza de reunir
Impacts of the 2017 Brazilian National Primary Care Policy on public primary health care in Rio de Janeiro, Brazil
In 2017, in a scenario of financial restrictions caused by an economic crisis in Brazil, a new primary health care policy promoted changes in the way different primary health care models were prioritized and implemented, with possible negative effects on the access to primary health care. This study aims to investigate if the 2017 Brazilian National Primary Care Policy (PNAB) negatively affected the primary care organization based on the Family H…
Critical Drugs for Critical Care: Protecting the US Pharmaceutical Supply in a Time of Crisis
Critical Drugs for Critical Care: Protecting the US Pharmaceutical Supply in a Time of Crisis Mariana P. Socal MD, PhD, Joshua M. Sharfstein MD, and Jeremy A. Greene MD, PhD Affiliation Mariana P. Socal and Joshua M. Sharfstein are with the Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. Jeremy A. Greene is with the Department of History of Medicine and the Center for Medical Humanities …
Links Between Chronic Illness and Late-Life Cognition: Evidence From Four Latin American Countries
These results suggest that returns from preventive policies to reduce cognitive decline would increase if they were targeted to seniors with chronic conditions and implemented before the impact from multiple comorbidities makes the cognitive decline too steep to be reversed
Links Between Chronic Illness and Late-Life Cognition: Evidence From Four Latin American Countries
These results suggest that returns from preventive policies to reduce cognitive decline would increase if they were targeted to seniors with chronic conditions and implemented before the impact from multiple comorbidities makes the cognitive decline too steep to be reversed
The challenging nature of gathering evidence and analyzing the judicialization of health in Brazil
de coletar evidncias e analisar a judicializao da sade no Brasil La desafiante naturaleza de reunir
Judicialization 2.0: Understanding right-to-health litigation in real time
Over the past two decades, debate over the whys, the hows, and the effects of the ever-expanding phenomenon of right-to-health litigation ('judicialization') throughout Latin America have been marked by polarised arguments and limited information. In contrast to claims of judicialization as a positive or negative trend, less attention has been paid to ways to better understand the phenomenon in real time. In this article, we propose a new approac…
Older Americans’ Preferences Between Lower Drug Prices and Prescription Drug Plan Choice, 2019
Objectives. To assess older Americans’ willingness to trade off the possibility of choosing or changing their prescription drug plan for lower drug spending. Methods. We used data from the Kaiser Family Foundation Health Tracking Poll on prescription drugs carried out in February 2019. This nationwide telephone survey oversampled participants aged 65 years and older who, when weighted, were representative of the US older adult population. Results…
Critical Drugs for Critical Care: Protecting the US Pharmaceutical Supply in a Time of Crisis
Critical Drugs for Critical Care: Protecting the US Pharmaceutical Supply in a Time of Crisis Mariana P. Socal MD, PhD, Joshua M. Sharfstein MD, and Jeremy A. Greene MD, PhD Affiliation Mariana P. Socal and Joshua M. Sharfstein are with the Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. Jeremy A. Greene is with the Department of History of Medicine and the Center for Medical Humanities …
The Pandemic and the Supply Chain: Gaps in Pharmaceutical Production and Distribution
Trends of Prescription Drug Manufacturer Rebates in Commercial Health Insurance Plans, 2015-2019
This economic evaluation examines the magnitude and trend of prescription drug rebates in commercial markets from 2015 to 2019 and identifies insurance plan factors associated with rebates
Impacts of the 2017 Brazilian National Primary Care Policy on public primary health care in Rio de Janeiro, Brazil
In 2017, in a scenario of financial restrictions caused by an economic crisis in Brazil, a new primary health care policy promoted changes in the way different primary health care models were prioritized and implemented, with possible negative effects on the access to primary health care. This study aims to investigate if the 2017 Brazilian National Primary Care Policy (PNAB) negatively affected the primary care organization based on the Family H…
US Antibiotic Importation and Supply Chain Vulnerabilities
This study found that US antibiotic importation relies on diversified global sources for FDFs but primarily on China for APIs. Policies to strengthen domestic production and diversify sourcing are critical to mitigate supply chain vulnerabilities. Improved traceability and targeted strategies for specific antibiotics are recommended to safeguard public health and national security
Medicine (6 works) · Business (5 works) · Economics (4 works) · Environmental health (4 works) · Health care (3 works) · Pharmaceutical Economics and Policy (3 works) · Political science (3 works) · Coronavirus disease 2019 (COVID-19) (2 works) · Demography (2 works) · Drug (2 works)